Clinical Trial Update: A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of MEDI-546 in Systemic Lupus Erythematosus was completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MEDI-546

Snippet

Sponsor: MedImmune LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2016-08-15